These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Angiogenesis in normal, hyperplastic, and neoplastic endometrium. Morgan KG; Wilkinson N; Buckley CH J Pathol; 1996 Jul; 179(3):317-20. PubMed ID: 8774489 [TBL] [Abstract][Full Text] [Related]
4. [Thymidine phosphorylase activity and neo-angiogenesis in ovarian cancer]. Wójcik-Krowiranda K; Miszczak-Zaborska E; Gottwald L; Bieńkiewicz A Ginekol Pol; 2003 Sep; 74(9):911-7. PubMed ID: 14674144 [TBL] [Abstract][Full Text] [Related]
5. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma. Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121 [TBL] [Abstract][Full Text] [Related]
6. [Influence of the selected pyrimidine compounds on the activity of thymidine phosphorylase from normal and tumor endometrial cells]. Miszczak-Zaborska E; Smolarek M; Dramiński M; Kubiak R; Józwiak B; Bartkowiak J Ginekol Pol; 2009 Aug; 80(8):590-5. PubMed ID: 19824457 [TBL] [Abstract][Full Text] [Related]
7. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium. Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer. Mazurek A; Kuc P; Terlikowski S; Laudanski T Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195 [TBL] [Abstract][Full Text] [Related]
9. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer. Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067 [TBL] [Abstract][Full Text] [Related]
10. Cytological evaluation of angiogenesis in endometrial aspirates. Ono M; Shiina Y Cytopathology; 2001 Feb; 12(1):37-43. PubMed ID: 11256935 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium. Cormio A; Guerra F; Cormio G; Pesce V; Fracasso F; Loizzi V; Resta L; Putignano G; Cantatore P; Selvaggi LE; Gadaleta MN BMC Res Notes; 2012 Jun; 5():279. PubMed ID: 22676897 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Zhang L; Mackenzie IZ; Rees MC; Bicknell R Endocrinology; 1997 Nov; 138(11):4921-30. PubMed ID: 9348223 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of phophatase and tensin homologue in normal, hyperplastic and neoplastic endometrium. Shawana S; Kehar SI; Shaikh F J Pak Med Assoc; 2014 Oct; 64(10):1103-8. PubMed ID: 25823145 [TBL] [Abstract][Full Text] [Related]
14. Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice. Bajwa P; Nielsen S; Lombard JM; Rassam L; Nahar P; Rueda BR; Wilkinson JE; Miller RA; Tanwar PS Oncotarget; 2017 Jan; 8(5):7265-7275. PubMed ID: 27980219 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemistry and activities of thymidine phosphorylase in the tissues of uterine cervical and endometrial carcinomas]. Kamoi S; Kawamoto M; Ohta Y; Takahashi H; Araki T Gan To Kagaku Ryoho; 1996 May; 23(6):801-4. PubMed ID: 8645034 [No Abstract] [Full Text] [Related]